One Business Partner Managed a Billion-Dollar Portfolio at Barclays, the Other Heads an Ivy League Medical School Department. Can They Create a Unicorn Together?

Michael Nelson is the CEO of Intrommune Therapeutics, while Dr. Bill Reisacher sits on its scientific advisory board.

Leave a Reply

Your email address will not be published. Required fields are marked *